Kuwait vs Turkmenistan: Cause of death, by non-communicable diseases, male
Kuwait
61.6%
in 2021
Turkmenistan
61.2%
in 2021
Kuwait rank
84th
Turkmenistan rank
87th
Cause of death, by non-communicable diseases, male over time
- Kuwait
- Turkmenistan
How they compare
Kuwait currently reports 61.6% against 61.2% in Turkmenistan, a difference of 0.4%.
Across all 6 years both countries report, Kuwait has been ahead every year.
Kuwait ranks 84th and Turkmenistan ranks 87th of 185 countries.
Kuwait has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kuwait | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 70.7% | 60.8% | 9.9% | Kuwait |
| 2010s | 75.7% | 62.8% | 12.8% | Kuwait |
| 2020s | 63.8% | 60.8% | 3.0% | Kuwait |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, male, Kuwait or Turkmenistan?
- Kuwait, at 61.6% against 61.2% in Turkmenistan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, male between Kuwait and Turkmenistan?
- 0.4%, with Kuwait ahead.
- How many years of comparable data are there for Kuwait and Turkmenistan?
- 6 years are reported by both, from 2000 to 2021.
- How do Kuwait and Turkmenistan rank globally for cause of death, by non-communicable diseases, male?
- Kuwait ranks 84th and Turkmenistan ranks 87th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.